Vancouver
Goyal A, Tiwari N, Patawa R. Co-Morbidity and COVID-19: A Study of Case Severity and Early Outcome. J CLIN EXP INVEST. 2022;13(1):em00790. https://doi.org/10.29333/jcei/11583
APA
Goyal, A., Tiwari, N., & Patawa, R. (2022). Co-Morbidity and COVID-19: A Study of Case Severity and Early Outcome. Journal of Clinical and Experimental Investigations, 13(1), em00790. https://doi.org/10.29333/jcei/11583
AMA
Goyal A, Tiwari N, Patawa R. Co-Morbidity and COVID-19: A Study of Case Severity and Early Outcome. J CLIN EXP INVEST. 2022;13(1), em00790. https://doi.org/10.29333/jcei/11583
Chicago
Goyal, Ankita, Nitin Tiwari, and Rohit Patawa. "Co-Morbidity and COVID-19: A Study of Case Severity and Early Outcome". Journal of Clinical and Experimental Investigations 2022 13 no. 1 (2022): em00790. https://doi.org/10.29333/jcei/11583
Harvard
Goyal, A., Tiwari, N., and Patawa, R. (2022). Co-Morbidity and COVID-19: A Study of Case Severity and Early Outcome. Journal of Clinical and Experimental Investigations, 13(1), em00790. https://doi.org/10.29333/jcei/11583
MLA
Goyal, Ankita et al. "Co-Morbidity and COVID-19: A Study of Case Severity and Early Outcome". Journal of Clinical and Experimental Investigations, vol. 13, no. 1, 2022, em00790. https://doi.org/10.29333/jcei/11583